PROGRAM OVERVIEW

Please note that this is a preliminary program as per 26 March 2021 and may be subject to change.

000

WEDNESDAY 30 JUNE

 

09.00 – Virtual exhibition opens
10.00 – 10.30 Opening presentations
Conference President and IFPA President opening lectures
10.30 – 11.10 Plenary/symposium session – Pathogenesis
  Pathogenesis of psoriasis
Professor Johan Gudjonsson, US
  Pathogenesis of psoriatic arthritis
Professor Vinod Chandran, Canada
  Studio discussion, Q & A
11.10 – 11.50 Plenary symposium session – Treatment guidelines
  Treatment guidelines/best practice psoriasis – speaker TBC
  Treatment guidelines/best practice psoriasis PsA
Professor Arthur Kavanaugh, US
  Studio discussion, Q & A
11.50 – 12.10 Break/digital mingle and meet-ups
12.10 – 12.50 Plenary/symposium session – New treatments
  New treatments/pipeline psoriasis
Professor Kristian Reich, Germany
  New treatments/pipeline PsA
Professor Philip Mease, US
  Studio discussion, Q & A
12.50 – 13.00 Oral abstract presentations
13.00 – 14.00 Break in the main program
  13.00 – 14.00 Complementary program/Civil society meeting
  13.00 – 14.00 Virtual poster walk/ poster “flash”
  13.10 – 13.55 Satellite symposium 1
14.00 – 14.45 Keynote lecture
  New pathways/drivers of immunity
Professor Kenji Kabashima, Japan
  Studio discussion, Q & A
14.45 – 15.00 Break/digital mingle and meet-ups
15.00 – 15.45 Keynote lecture
  Patient reported outcomes measures – measuring wellbeing not only burden of disease
Dr. Rachel Sommer, Germany
  Studio discussion, Q & A
15.45 – 16.00 Main program concludes – summary/highlights
16.00 – 17.00 16.00 – 17.00 Complementary program/Civil society meeting
  16.15 – 17.00 Satellite symposium 2

 

THURSDAY 1 JULY

 

09.00 – 09.45 Satellite symposium 3
10.00 – 10.50 Interactive discussion session
The role of doctor/patient communication in improving outcomes and wellbeing
  Listening is learning – the patient perspective
Silvia Fernandez Barrio, Argentina
  The importance of communication in treating persons with chronic, inflammatory disease
Professor Katy Leung, Singapore
  Telemedicine as a tool for communication – speaker TBC
  Interactive discussion
Poll, Q & A, studio participation
10.50 – 11.00 Short break
11.00 – 11.45 Keynote lecture
  Self-responsibility and self-management – encouraging lasting behaviour change in patients with psoriasis/psoriatic arthritis
Professor Christine Bundy, United Kingdom
11.45 – 11.50 Short break
11.50 – 12.00 Oral abstract presentations
12.00 – 12.45 Keynote lecture
  The general impact of the microbiome in chronic, inflammatory disease – speaker TBC
  Studio discussion, Q & A
13.00 – 14.00 Break in main program
  13.00 – 14.00 Complementary program/Civil society meeting
  13.00 – 14.00 Virtual poster walk/poster “flash”
  13.10 – 13.55 Satellite symposium 4
14.00 – 14.45 Joint IFPA/ GRAPPA session
Moderators: Professor Kristina Callis Duffin, US, Professor Ulrich Mrowietz, Germany
  Palmoplantar pustulosis
  The challenge of living with PPP
Filmed testimonials from people living with PPP – IFPA set up 
  Skin manifestations and clinical features
  Rheumatological manifestations and clinical features
Professor Philip Helliwell, UK
  Outcomes measures
Professor Melissa Oliver, US
  Studio discussion, Q & A
14.45 – 15.00 Break/digital mingle and meet-ups
15.00 – 15.45 Joint session continued
Presentation of GRAPPA projects
  Introduction
Professor Kristina Callis Duffin, US
  Axial PsA – the AXIS project
Professor Dafna Gladman, Canada
  Composite measures
Professor William Tillet, United Kingdom
  Innovative Medicines
Initiative grant: Unmet needs in psoriatic arthritis
Professor Oliver FitzGerald, Ireland
  Educational projects
Professor Philip Mease, US
15.45 – 16.00 Main program concludes – summary/highlights
16.00 – 17.00 16.00 – 17.00 Complementary program/civil society meeting
  16.15 – 17.00 Satellite symposium 5
FRIDAY 2 JULY

 

09.00 – 09.45 Satellite symposium 6
10.00 – 11.00 Plenary/symposium session
Comorbidity update
  Comorbidity in adult psoriasis
  Matching comorbidity in psoriasis and PsA
Professor Alexis Ogdie-Beatty, US
  Comorbidity in children and young adults – speaker TBC
  Studio discussion, Q & A
11.00 – 11.10 Short break
11.10 – 11.50 Session continues
Prevention series
  Can we prevent disease progression in psoriasis?
Professor Wayne Gulliver, Canada
  Can we prevent progression to psoriatic arthritis? – speaker TBC
  Prevention and reduction of disease through weight-loss
Dr. Alexander Egeberg, Denmark
  Studio discussion, Q & A
11.50 – 12.00 Oral abstract session
12.00 – 12.10 Short break
12.10 – 13.00 Plenary/symposium session
20 years of biologics
  Looking back and looking ahead – long-term safety, risk management and future potential
Professor Carle Paul, France
  Treatment strategies – unmet needs of treating psoriasis/psoriatic arthritis
Professor Kilian Eyerich, Sweden
  Potential for prevention of comorbidity
Professor Wolf-Henning Boehncke, Switzerland
Professor Dafna Gladman, Canada
  Studio discussion, Q & A
13.00 – 14.00 Break in the main program
  13.00 – 14.00  Complementary program/Civil society meeting
  13.00 – 14.00 Virtual poster walk/poster “flash”
  13.10 – 13.55 Satellite symposium 7
14.00 – 14.45 Keynote lecture
  Vasculation inflammation in chronic inflammatory disease
Professor Nehal Meta, US
  Studio discussion, Q & A
14.45 – 15.00 Break/digital mingle and meet-ups
15.00 – 15.45 Keynote lecture
  Pathogenesis of depression in inflammation (chronic and acute)
Professor Mats Lekander, Sweden
  Studio discussion, Q & A
15.45 – 16.00 Main program concludes – summary/highlights
16.00 – 17.00 16.00 – 17.00 Complementary program/Civil society meeting
  16.15 – 17.00 Satellite symposium 8
SATURDAY 3 JULY

 

09.00 – 09.45 Satellite symposium 9
10.00 – 11.00 Interactive discussion session
Adressing unmet needs in psoriasis and psoriatic arthritis
  The WHO Global report on psoriasis – suggested actions to improve treatment and care for people with psoriasis
Professor Josef de Guzman, Phillipines
  Unmet needs in psoriatic arthritis – speaker TBC
  Health economics and access to treatment
Professor Ricardo Romiti, Brazil
  Interactive discussion
Poll, Q & A, studio discussion
11.00 – 11.10 Short break
11.10 – 11.35 Unmet needs session continued
Adressing stigmatization in psoriasis
  The global need for active measures against stigmatization
Professor Ncoza Dhlova, South Africa
  Strategies to reduce stigma – learnings from the German national programme against stigmatization
Professor Matthias Augustin, Germany
  Studio discussion, Q & A
11.35 – 12.00 “Hot topic session” – hit early, hit hard
  Pro
Professor Lluis Puig, Spain
  Studio discussion, Q & A
  Con – speaker TBC
12.00 – 12.10 Short break
12.10 – 12.20 Oral abstract presentations
12.20 – 13.00 Plenary/symposium session
Topical therapy
  Is there still a place for topical treatment?
Professor Lars Iversen, Denmark
  New topical developments – speaker TBC
  Measures to improve adherence to topical treatment
Professor Wolfgang Weger, Austria
  Studio discussion, Q & A
13.00 – 14.00 Break in the main program
  13.00 – 14.00  Complementary program/Civil society meeting
  13.00 – 14.00 Virtual poster walk/poster “flash”
  13.10 – 13.55 Satellite symposium 10
14.00 – 14.45 Keynote lecture
Psoriasis, psoriatic arthritis and infectious disease – speaker TBC
  Studio discussion, Q & A
14.45 – 15.00 Break/digital mingle and meet-ups
15.00 – 15.30 Plenary/symposium session
Consequences of the corona pandemic on the management of psoriasis and psoriatic arthritis
  Are early registry data helpful for risk assessments?
Professor Jo Lambert, Belgium
  SARS-CoV-2 vaccination management in psoriasis and PsA
Professor Paolo Gisondi, Italy
15.30 – 16.15 Awards session – poster presentations
16.15 – 16.30 Conclusion of conference
Final panel discussion on conference theme and highlights – IFPA President + SEC members

IFPA Secretariat
Gustavslundsvägen 143
167 51 Bromma, SWEDEN
ifpa-pso.com

The International Federation of Psoriasis Associations is a non-profit organization representing millions of people living with psoriasis or psoriatic arthritis worldwide.

Conference Bureau:
Meetagain Konferens AB
Email: ifpaworldconference@meetagain.se